Clinical Trials in Massachusetts

Showing 15841-15860 of 17,868 trials

Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma

NCT00483262

The purpose of this research study is to determine the safety of CCI-779 (Temsirolimus) and bortezomib (Velcade), and the highest dose of this drug that can be given to people safely. We will also be looking at how the combination of the two drugs may work against multiple myeloma. CCI-779 (Temsirolimus) is a drug that appears to stop myeloma cells from growing.

Multiple Myeloma

Dana-Farber Cancer Institute63 participantsStarted May 2007

Boston, Massachusetts, United States • Ann Arbor, Michigan, United States • St Louis, Missouri, United States

TERMINATEDPhase 226 miles

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

NCT00003292

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of ifosfamide in treating patients with meningeal tumors that have recurred or that cannot be removed surgically.

ChondrosarcomaAdult FibrosarcomaAdult Leiomyosarcoma+3 more

SWOG Cancer Research Network7 participantsStarted Jul 1998

Scottsdale, Arizona, United States • Duarte, California, United States • Palo Alto, California, United States +67 more locations

Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma

S9624 Ifosfamide in Treating Patients With Meningeal Tumors

Find Trials by Condition in Massachusetts

Monoclonal Antibody Therapy in Treating Patients With Residual Disease From Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer Following Surgery and Chemotherapy

Cytarabine With or Without VNP40101M in Treating Patients With Relapsed Acute Myeloid Leukemia

Radiation Therapy in Treating Patients With Stage I or Stage II Prostate Cancer

Acceptance-Based Treatment for Generalized Anxiety Disorder

Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis

Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

Investigation of Efficacy, Safety and Tolerability of Once and Twice Daily Doses of AZD1981 in Asthmatic Patients

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

Spiriva® Assessment of FEV1 (SAFE)

ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen

Study of Aripiprazole in Patients With Acute Bipolar Mania

Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer